NCT01514695View on ClinicalTrials.gov

Fentanyl Use for Sedation in Esophagogastroduodenoscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Endoscopy
Interventions
DRUG

Midazolam

Starting with 1mg intravenously in all patients. More can be added at the discretion of the physician as needed for sedation.

DRUG

Fentanyl

100mcg intravenously given in 2mL syringe at start of procedure

OTHER

Placebo

One dose of saline (2ml)

Trial Locations (1)

L8N4A6

St Joseph's Healthcare Hamilton, Hamilton

All Listed Sponsors
collaborator

McMaster University

OTHER

lead

St. Joseph's Healthcare Hamilton

OTHER

NCT01514695 - Fentanyl Use for Sedation in Esophagogastroduodenoscopy | Biotech Hunter | Biotech Hunter